Protein-directed nucleotide selection in the DRT3 defense system: mechanism, biological context, and constraints on programmability.

The DRT3 bacterial defense system reveals a previously undocumented mode of specificity in DNA synthesis, wherein a protein active site, rather than a complementary nucleic acid strand, dictates nucleotide incorporation. This mechanism necessitates a precise spatial configuration. DRT3 does not encode a protein-to-DNA sequence transfer; rather, it produces a singular repetitive product, an alternating poly (GT/AC) double-stranded DNA, whose sequence is constrained by the geometry of the Drt3b active site. Structural and biochemical analyses of the reconstituted Escherichia coli system reveal a ribonucleoprotein complex comprising two reverse-transcriptase-like proteins (Drt3a and Drt3b) and a non-coding RNA scaffold, assembled into a D3-symmetric 6:6:6 architecture at 2.2-2.6 Å resolution. Drt3a synthesizes the poly (GT) strand utilizing a conserved RNA motif as a Watson-Crick template, whereas Drt3b generates the complementary poly (AC) strand independently of a nucleic acid template, consistent with the absence of templating nucleic-acid density in its active site. This review contextualizes the discovery of DRT3 within the broader evolution of DNA synthesis biochemistry and defense-associated reverse transcriptases and elucidates the mechanistic foundation of protein-directed nucleotide selection. Three primary constraints are emphasized: First, the system demonstrates structural control of sequence specificity without programmability; there is no evidence for the engineering of alternative motifs. Second, no therapeutic application based on DRT3 has been validated in mammalian systems or